NO895087L - Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. - Google Patents

Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater.

Info

Publication number: NO895087L
Authority: NO; Norway
Prior art keywords: eter; derivatives; procedure; preparation; therapeutic active
Prior art date: 1988-12-23

Application number

NO89895087A

Other languages

English (en)

Norwegian (no)

Other versions

NO895087D0 (no

Inventor

Annie Hamon

Original Assignee

Ici Pharma

Ici Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-12-23

Filing date

1989-12-18

Publication date

1990-06-25

1989-12-18 Application filed by Ici Pharma, Ici Plc filed Critical Ici Pharma

1989-12-18 Publication of NO895087D0 publication Critical patent/NO895087D0/no

1990-06-25 Publication of NO895087L publication Critical patent/NO895087L/no

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings

Landscapes

Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
Plural Heterocyclic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

NO89895087A 1988-12-23 1989-12-18 Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. NO895087L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP88403311		1988-12-23

Publications (2)

Publication Number	Publication Date
NO895087D0 NO895087D0 (no)	1989-12-18
NO895087L true NO895087L (no)	1990-06-25

Family

ID=8200452

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO89895087A NO895087L (no)	1988-12-23	1989-12-18	Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater.

Country Status (17)

Country	Link
US (1)	US5098932A (fr)
EP (1)	EP0375457B1 (fr)
JP (1)	JPH03135976A (fr)
AU (1)	AU622965B2 (fr)
CA (1)	CA2006095A1 (fr)
DE (1)	DE68913940T2 (fr)
DK (1)	DK665089A (fr)
ES (1)	ES2063149T3 (fr)
FI (1)	FI896015A7 (fr)
GB (1)	GB8927287D0 (fr)
HU (1)	HUT52494A (fr)
IE (1)	IE63211B1 (fr)
IL (1)	IL92580A (fr)
NO (1)	NO895087L (fr)
NZ (1)	NZ231666A (fr)
PT (1)	PT92701A (fr)
ZA (1)	ZA899688B (fr)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IE902113A1 (en) *	1989-07-18	1991-06-19	Ici Plc	Diaryl ether cyclic ethers
US5254581A (en) *	1990-06-21	1993-10-19	Imperial Chemical Industries Plc	Pyran derivatives and their use as inhibitors of 5-lipoxygenase
IE914005A1 (en) *	1990-12-14	1992-06-17	Zeneca Ltd	Novel intermediates
CA2058254A1 (fr) *	1991-01-15	1992-07-16	John Francis Kingston	Derives de benzodioxole
US5258399A (en) *	1991-01-17	1993-11-02	Imperial Chemical Industries Plc	Sulphonamide derivatives
IL100483A0 (en) *	1991-01-17	1992-09-06	Ici Plc	Sulphonamide derivatives
EP0505122A1 (fr) *	1991-03-21	1992-09-23	Zeneca Limited	Dérivés alpha, alpha-dialkylbenzyle
EP0532239B1 (fr) *	1991-09-10	1995-12-13	Zeneca Limited	Dérivés de benzenesulfonamide comme inhibiteurs de 5-lipoxygenase
EP0555067A1 (fr) *	1992-02-07	1993-08-11	Zeneca Limited	Dérivés d'hydroxylamine comme inhibiteurs de 5-lipoxygénase
GB9300894D0 (en) *	1992-02-07	1993-03-10	Zeneca Ltd	Oxime derivatives
CA2094465A1 (fr) *	1992-04-23	1993-10-24	Pierre Andre Raymond Bruneau	Derives de cycloalcane
CA2095006A1 (fr) *	1992-05-12	1993-11-13	Philip Neil Edwards	Derives oxime
CA2095005A1 (fr) *	1992-05-12	1993-11-13	Philip Neil Edwards	Derives hydroxylamine
US5231197A (en) *	1992-06-01	1993-07-27	General Electric Company	Method for producing ethylenically unsaturated graftable orthoesters
DE4228201A1 (de) *	1992-08-25	1994-03-03	Schering Ag	Neue Leukotrien-B¶4¶-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
AU4444393A (en) *	1992-09-01	1994-03-10	Zeneca Limited	Pyrrolidine derivatives
WO1994005638A1 (fr) *	1992-09-02	1994-03-17	Abbott Laboratories	Composes de trans 1,4-diethercyclohexane utilises en tant qu'inhibiteurs de la 5-lipoxygenase
US5407959A (en) *	1993-11-12	1995-04-18	Abbott Laboratories	(Trans-1,4-dialkoxycyclohexyl) substituted arylalkylaryl-arylalkenylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase
US5446062A (en) *	1993-11-12	1995-08-29	Abbott Laboratories	((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and arylalkynyl)urea inhibitors of 5-lipoxygenase
WO1996038418A1 (fr)	1995-06-02	1996-12-05	G.D. Searle & Co.	Derives heterocyclo-substitues d'acide hydroxamique utilises comme inhibiteurs de la cyclo-oxygenase-2 et de la 5-lipoxygenase
US6515014B2 (en)	1995-06-02	2003-02-04	G. D. Searle & Co.	Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US5643933A (en) *	1995-06-02	1997-07-01	G. D. Searle & Co.	Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
US6512121B2 (en)	1998-09-14	2003-01-28	G.D. Searle & Co.	Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors
WO1996041626A1 (fr) *	1995-06-12	1996-12-27	G.D. Searle & Co.	Compositions comprenant un inhibiteur de cyclooxygenase-2 et un inhibiteur de 5-lipoxygenase
DK0880363T3 (da) *	1996-02-13	2003-01-20	Searle & Co	Kombinationer der omfatter en cyclooxygenase-2 hæmmer samt en leukotrien A4 hydrolasehæmmer, som har immunsuppressive virkninger
DE69709069T2 (de)	1996-02-13	2002-07-04	G.D. Searle & Co., Chicago	Zusammensetzungen mit immunosuppressiven wirkungen, welche 5-lipoxygenase-inhibitoren und cyclooxygenase-2-inhibitoren enthalten
US6677364B2 (en)	1998-04-20	2004-01-13	G.D. Searle & Co.	Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors
AU1820002A (en) *	2000-10-03	2002-04-15	Syngenta Participations Ag	Phenylpropynyloxypyridine herbicides
EP3539560A1 (fr)	2007-02-22	2019-09-18	Children's Hospital & Research Center at Oakland	Formulations d'acides gras, et leurs procédés d'utilisation
ES2950469T3 (es)	2016-03-03	2023-10-10	Univ De Moncton	Moduladores de la actividad enzimática de lipooxigenasas y ciclooxigenasas

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3743737A (en) *	1970-05-21	1973-07-03	Smith Kline French Lab	3-sulfonamido-4-hydroxyphenyl-2-piperindinylcarbinol compositions
US3661917A (en) *	1970-05-21	1972-05-09	Smith Kline French Lab	3-sulfonamido-4-hydroxyphenyl-2-piperidylcarbinols
CA960676A (en) *	1970-05-21	1975-01-07	Smith Kline And French Canada Ltd.	3-sulfonamido-4-hydroxyphenyl-2-piperidinylcarbinols
IE56702B1 (en) *	1982-12-01	1991-11-06	Usv Pharma Corp	Antiinflammatory antiallergic compounds
NO174506B (no) *	1984-10-30	1994-02-07	Usv Pharma Corp	Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser
US4625034A (en) *	1985-02-04	1986-11-25	Usv Pharmaceutical Corp.	1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4839369A (en) *	1985-04-16	1989-06-13	Rorer Pharmaceutical Corporation	Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4876346A (en) *	1985-05-02	1989-10-24	American Home Products Corporation	Quinoline compounds
EP0271287A3 (fr) *	1986-12-11	1990-06-13	Merck Frosst Canada Inc.	Acides quinoléine dicarboxyliques et leurs amides
US4920132A (en) *	1987-11-03	1990-04-24	Rorer Pharmaceutical Corp.	Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920133A (en) *	1987-11-03	1990-04-24	Rorer Pharmaceutical Corp.	Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920130A (en) *	1987-11-02	1990-04-24	Rorer Pharamceutical Corp.	Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4920131A (en) *	1987-11-03	1990-04-24	Rorer Pharmaceutical Corp.	Quinoline derivatives and use thereof as antagonists of leukotriene D4
US4918081A (en) *	1988-06-20	1990-04-17	Rorer Pharmaceutical Corp.	Quinoline derivatives and use thereof as antagonists of leukotriene d4
EP0349062A1 (fr) *	1988-06-27	1990-01-03	Merck Frosst Canada Inc.	Acides quinolineétheralkanoiques

1989
- 1989-12-01 GB GB898927287A patent/GB8927287D0/en active Pending
- 1989-12-05 IE IE388189A patent/IE63211B1/en not_active IP Right Cessation
- 1989-12-06 IL IL9258089A patent/IL92580A/xx not_active IP Right Cessation
- 1989-12-07 NZ NZ231666A patent/NZ231666A/en unknown
- 1989-12-15 HU HU896627A patent/HUT52494A/hu unknown
- 1989-12-15 FI FI896015A patent/FI896015A7/fi not_active Application Discontinuation
- 1989-12-18 ZA ZA899688A patent/ZA899688B/xx unknown
- 1989-12-18 NO NO89895087A patent/NO895087L/no unknown
- 1989-12-20 CA CA002006095A patent/CA2006095A1/fr not_active Abandoned
- 1989-12-21 AU AU47147/89A patent/AU622965B2/en not_active Ceased
- 1989-12-22 EP EP89313521A patent/EP0375457B1/fr not_active Expired - Lifetime
- 1989-12-22 DE DE68913940T patent/DE68913940T2/de not_active Expired - Fee Related
- 1989-12-22 PT PT92701A patent/PT92701A/pt not_active Application Discontinuation
- 1989-12-22 ES ES89313521T patent/ES2063149T3/es not_active Expired - Lifetime
- 1989-12-22 US US07/454,911 patent/US5098932A/en not_active Expired - Fee Related
- 1989-12-22 DK DK665089A patent/DK665089A/da not_active Application Discontinuation
- 1989-12-25 JP JP1333011A patent/JPH03135976A/ja active Pending

Also Published As

Publication number	Publication date
AU4714789A (en)	1990-06-28
IE893881L (en)	1990-06-23
NZ231666A (en)	1992-01-29
HUT52494A (en)	1990-07-28
EP0375457A2 (fr)	1990-06-27
PT92701A (pt)	1990-06-29
DK665089D0 (da)	1989-12-22
DE68913940D1 (de)	1994-04-21
ZA899688B (en)	1990-08-29
FI896015A7 (fi)	1990-06-24
DE68913940T2 (de)	1994-07-14
EP0375457B1 (fr)	1994-03-16
IL92580A (en)	1994-04-12
IE63211B1 (en)	1995-04-05
EP0375457A3 (fr)	1991-01-09
US5098932A (en)	1992-03-24
DK665089A (da)	1990-06-24
NO895087D0 (no)	1989-12-18
GB8927287D0 (en)	1990-01-31
AU622965B2 (en)	1992-04-30
JPH03135976A (ja)	1991-06-10
IL92580A0 (en)	1990-08-31
ES2063149T3 (es)	1995-01-01
CA2006095A1 (fr)	1990-06-23
FI896015A0 (fi)	1989-12-15

Publication	Publication Date	Title
NO895087D0 (no)	1989-12-18	Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater.
NO894630L (no)	1990-05-23	Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater.
NO871266L (no)	1987-09-28	Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO883974D0 (no)	1988-09-07	Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO904694L (no)	1991-05-02	Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684D0 (no)	1990-04-17	Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO870526L (no)	1987-08-13	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no)	1988-03-28	Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO874153D0 (no)	1987-10-02	Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO883122D0 (no)	1988-07-13	Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO875488D0 (no)	1987-12-30	Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO893909L (no)	1990-04-04	Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater.
NO862372D0 (no)	1986-06-13	Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater.
NO891723L (no)	1989-10-30	Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO167739C (no)	1991-12-04	Anologifremgangsmaate for fremstilling av terapeutisk aktive ginkolid-derivater.
NO891114D0 (no)	1989-03-15	Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO167802C (no)	1991-12-11	Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO864101D0 (no)	1986-10-14	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater.
NO900972D0 (no)	1990-03-01	Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO890607L (no)	1989-08-17	Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater.
NO871907D0 (no)	1987-05-07	Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO874780D0 (no)	1987-11-17	Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO913187D0 (no)	1991-08-15	Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater.
NO900942D0 (no)	1990-02-28	Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO890724D0 (no)	1989-02-21	Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater.